Document:

Exhibit

EXHIBIT 10.1

AMENDMENT NO. 2 TO SECOND AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT

This Amendment No. 2 to Second Amended and Restated Credit and Security Agreement, dated as of April 30, 2016 (this “Second Amendment”) is by and among Smithfield Receivables Funding LLC, a Delaware limited liability company (“Borrower”), Smithfield Foods, Inc., a Virginia corporation (“Smithfield”), as initial servicer (the “Servicer” together with Borrower, the “Loan Parties” and each, a “Loan Party”), Coöperatieve Rabobank, U.A. (formerly known as Coöperatieve Centrale Raiffeisen-Boerenleenbank B.A., “Rabobank Nederland”), New York Branch (“Rabobank”), in its capacity as administrative agent (the “Administrative Agent” collectively with the Administrative Agent and Co-Agents, the “Agents”) and in its capacity as letter of credit issuer (the “Letter of Credit Issuer”), and the Lenders and the Co-Agents from time to time party to that certain Second Amended and Restated Credit and Security Agreement.  Each of the Loan Parties, the Agents, the Letter of Credit Issuer, the Lenders and the Co-Agents may be referred to herein as a “Party” or collectively as the “Parties.” 

PRELIMINARY STATEMENTS

WHEREAS, each of the Parties is a party to that certain Second Amended and Restated Credit and Security Agreement dated as of April 28, 2014 among the Loan Parties, the Agents, the Letter of Credit Issuer, the Lenders and the Co-Agents (as amended prior to the date hereof, the “Original Agreement”); and

WHEREAS, the Parties desire to amend the Original Agreement in the manner set forth in this Second Amendment and in accordance with Section 14.1(b) of the Original Agreement.

NOW, THEREFORE, in consideration of the premises and the mutual agreements herein set forth, the Parties hereby agree as follows:

ARTICLE I
AMENDMENT

Section 1.1    Amendment.  With effect from April 30, 2016, Schedule A to the Original Agreement shall be hereby amended by deleting the reference to “$325,000,000” therein, and replacing it with “$275,000,000”.

Section 1.2     Effect of Amendment.  Except as expressly set forth herein, this Second Amendment shall not alter, modify, amend or in any way affect any of the terms, conditions, obligations, covenants or agreements contained in the Original Agreement, all of which are ratified and affirmed in all respects and shall continue in full force and effect.

Section 1.3    References.  On and after the effective date of this Second Amendment, each reference in the Original Agreement to “this Agreement”, “hereunder”, “hereof”, “herein” and words of similar import referring to the Original Agreement, and each reference in the other Transaction Documents to the “Credit and Security Agreement”, “thereunder”, “thereof” or words of similar import referring to the Original Agreement, shall mean a reference to the Original Agreement, as amended by and in accordance with this Second Amendment.

ARTICLE II
REPRESENTATIONS 

Section 2.1.    Each of the Loan Parties represents and warrants to the Agents and the Lenders on the date hereof that it has duly authorized, executed and delivered this Second Amendment and that this Second Amendment constitutes a legal, valid and binding obligation of such Party, enforceable against such Party in accordance with its terms (except as enforceability may be limited by applicable bankruptcy, insolvency,  reorganization or other similar laws relating to or limiting creditors’ rights generally and by general principles of equity (regardless of whether enforcement is sought in a proceeding in equity or at law)).
Section 2.2.      Each of the Loan Parties further represents and warrants to the Agents and the Lenders that, as of the date of this Second Amendment: (a) each of the representations and warranties made by it pursuant to Section 5.1 of the Original Agreement is true and correct as though made on and as of such date (except with respect to those representations and warranties that by their express terms relate solely to an earlier date) and (b) no event has occurred and is continuing that will constitute a Termination Event or an Unmatured Termination Event (as such terms are defined in the Receivables Sale Agreement).

ARTICLE III
MISCELLANEOUS

Section 3.1    Definitions; Interpretation.  All capitalized terms used but not otherwise defined herein shall have the meanings assigned thereto in the Original Agreement.

Section 3.2    Headings. The section headings contained in this Second Amendment are for reference purposes only and shall not affect the meaning or interpretation of this Second Amendment.

Section 3.3    Amendment.  No provision of this Second Amendment may be amended, modified or supplemented except by the written agreement of all of the Parties.    

Section 3.4    Counterparts.  This Second Amendment may be executed in any number of counterparts and by different Parties in separate counterparts, each of which when so executed shall be deemed to be an original and all of which when taken together shall constitute one and the same Agreement.

Section 3.5    Transaction Document. This Second Amendment shall constitute a Transaction Document.

Section 3.6    Miscellaneous.  Sections 14.5, 14.8, 14.9, 14.10 and 14.11 of the Original Agreement are incorporated by reference in and shall apply to this Second Amendment as if set out herein in their entirety.

<signature pages follow>

IN WITNESS WHEREOF, the Parties have caused this Second Amendment to be duly executed as of the date first above written.

SMITHFIELD RECEIVABLES FUNDING LLC,
AS BORROWER

By:  SFFC, Inc., its managing member

By:    /s/ Jeffrey A. Porter
Name:    Jeffrey A. Porter
Title:    President

		
	Address:  
	3411 Silverside Rd. 

Baynard Bldg., Suite 103
Wilmington, DE 19810
Attention: Jeffrey Porter  
Telecopy No.: 302-543-7574

With a copy to:    
c/o Smithfield Foods, Inc.
200 Commerce Street
Smithfield, VA 23430,
Attention: Timothy Dykstra 
Telecopy No.: 757-365-3070

SMITHFIELD FOODS, INC., 
AS SERVICER

By:    /s/ Timothy Dykstra
Name:    Timothy Dykstra
Title:    Vice President and Corporate Treasurer

		
	Address:
	Smithfield Foods, Inc.

200 Commerce Street
Smithfield, VA 23430,
Attention: Timothy Dykstra 
Telecopy No.: 757-365-3070
and Glenn Nunziata  
Telecopy No.: 757-365-3025

COÖPERATIEVE RABOBANK, U.A., NEW YORK BRANCH, 
AS ADMINISTRATIVE AGENT AND AS LETTER OF CREDIT ISSUER

By:    /s/ Christopher Lew
Name:    Christopher Lew
Title:    Executive Director

By:    /s/ Thomas McNamara
Name:    Thomas McNamara
Title:    Vice President

		
	Address:
	Securitization - Transaction Management 
Rabobank International 
245 Park Avenue 
New York, NY 10167

Email: tmteam@rabobank.com 
Phone:    (212) 808-6816 
Fax:    (914) 304-9324

COÖPERATIEVE RABOBANK, U.A., 
AS A COMMITTED LENDER

By:    /s/ E. van Esveld
Name:    E. van Esveld
Title:

By:    /s/ B de Boo
Name:    B de Boo
Title:    Director

		
	Address:
	Croeselaan 18

3521 CB Utrecht
Netherlands
Email: l.eu.TransactionManagement@rabobank.comExhibit 10.1

 

Confidential information has been omitted from portions of this
document, indicated by [*], and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to this omitted information.

 

AGREEMENT

 

This agreement ("Agreement")
is entered into by and between:

 

Phoenix
Digital Solutions LLC, a Delaware limited liability company
with its principal place of business at 701 Palomar Airport Road, Suite 170, Carlsbad, CA
92011-1045 ("PDS") and Map Licensing LLC, a California
limited liability company with its principal place of business
at 2310 Homestead Road, Suite C1-505, Los Altos, CA 94024, and Alliacense Limited LLC, a Delaware limited liability company with
its principal place of business at 4880 Stevens Creek Boulevard, #103, San
Jose, CA 95129 ("Alliacense").

 

1.     Project

 

1.1.     MMP Licensing shall provide IP commercialization services to PDS for the
commercialization of the MMP patent portfolio scheduled at Exhibit 1t o Addendum B (the "Patents"), to
the Project Group (the Licensing Group plus
the Litigation Group) of companies (scheduled at Addendum A) (the "Services").

 

1.1.1.     MMP
Licensing shall conduct a Patent infringement litigation campaign against a group of companies chosen by MMP Licensing from the
Project Group. Accordingly, PDS shall grant to MMP Licensing the license attached hereto at Addendum B.

 

1.1.1.1.     Once
such a campaign is initiated, MMP
Licensing shall have the option, upon consultation with PDS, to
pursue further such campaigns (and thus expand the Litigation Group of companies) provided PDS is not responsible for such
litigation attorney's fees or such litigation expenses; and accordingly, PDS
shall grant to MMP Licensing the license attached hereto at Addendum
B to enable such expansion.

 

1.1.2.     MMP
Licensing shall operate a Patent licensing program for those Project Group Companies that are not in the Litigation Group (the
"Licensing
Group").

 

1.1.3.     MMP
Licensing will provide updates every thirty days on its Services efforts
(or sixty days with respect to
Litigation) to PDS, and respond
in a timely manner to all reasonable requests by PDS for information regarding the status
and activities of
licensing and litigation efforts.

 

1.1.4.     MMP
Licensing shall conduct the Services such that Recovery is not comingled with recoveries from other IP commercialization services.

 

    	 	1	 

     

    

 

Confidential information has been omitted from portions of this
document, indicated by [*], and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to this omitted information.

 

1.2.     With respect the Patent infringement
litigation currently pending
in NDCA (the "NDCA
Cases"):

 

1.2.1.     In
the event such cases continue {as a result of a successful appeal for example), Alliacense shall cooperate with all reasonable
discovery requests {in the context), and shall provide support to litigation counsel through the provision of properly produced
and protected materials.

 

1.3.     Prior
to Project travel, MMP Licensing shall estimate in detail, and PDS shall pay to MMP Licensing, all reasonable travel expenses
that have been estimated by MMP Licensing and approved in writing by PDS in advance. MMP Licensing shall have no obligation to
incur expenses on behalf of PDS. Any expenses benefiting other MMP Licensing clients shall be equitably allocated.

 

2.     Distribution of Recovery

 

2.1.     MMP
Licensing shall be entitled to:

 

2.1.1.     [*]% of each Litigation Group Recovery and NDCA Case Recovery; and

 

2.1.2.     [*]%
of each Licensing Group Recovery; and

 

2.1.3.     [*]% of each Recovery from any entity not part of the Project Group.

 

2.2.     With respect to Licensing Group Recovery, MMP Licensing shall arrange the [*]% distribution to MMP Licensing, and the [*]% distribution
to PDS, to be paid as direct payments from each such Licensing Group company.

 

2.3.     With
respect Litigation Group Recovery, MMP Licensing shall arrange the [*]% distribution to MMP Licensing to be paid as a
direct payment from each such Litigation Group company, and shall arrange the [*]% remainder to be paid as a direct payment
from each such Litigation Group company to contingency litigation counsel ("CLC"), whom MMP Licensing shall
instruct to deduct its fees and expenses, and to remit the remaining balance to PDS.

 

2.3.1.     MMP Licensing shall endeavor to arrange for CLC and the funding of litigation expenses on the most favorable terms available
(in its reasonable business judgment), such that the combined total should not exceed [*]% of Recovery. The parties
acknowledge that such combined total may be significantly less than [*]%, by virtue of, for example, a stair-stepped milestone
plan.

 

2.3.2.     Prior to execution by MMP Licensing, MMP Licensing shall submit its proposed engagement agreement with the CLC (the
"CLCA") to PDS Counsel.

 

2.3.2.1.     The submitted CLCA shall be redacted so as to not reveal the identity of the CLC.

 

2.3.2.2.     Within 3 business days, PDS counsel may object to the proposed CLCA by submitting a Proper Objection. A Proper Objection is
an objection by PDS counsel that is accompanied by a writing detailing (1) the objection, (2) evidence substantiating its
belief that the proposed CLCA is objectively commercially unreasonable, and (3) a cure for its objection that, if
implemented, would not degrade MMP Licensing's rights or entitlements hereunder.

 

2.3.2.3.     In the event of a Proper Objection, MMP Licensing shall not execute the proposed CLCA until it resolves the objection.

 

    	 	2	 

     

    

 

Confidential information has been omitted from portions of this
document, indicated by [*], and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to this omitted information.

 

2.4.     With
respect to non Project Group Recovery, PDS shall arrange the [*]% distribution to Alliacense to be paid as direct payments from
each such non Project Group company.

 

2.5.     Unless otherwise agreed in writing by PDS and MMP Licensing, no other fees, costs or expenses shall be due to MMP Licensing for
the Services provided.

 

2.6.     "Recovery" means the gross amount of all cash received from the Licensing Companies and the Litigation Companies (including
its members, affiliates, successors and assigns) related to the Patents, whether for the performance of a service, the satisfaction
or release of any claim or transfer of any rights or benefits relating to the Patents. Recovery shall not include consideration
not actually received, such as tax withholdings or credits unless and until such withholdings or credits are refunded to or used
by a party.

 

3.     Settlement

 

3.1.     Within 24 hours of the execution of this agreement, Alliacense shall provide the MMP Materials for the Group 1 companies (as already
produced in the Arbitration) (the "Materials") to DHG under the terms of the NOA already executed by DHG on 31 JAN 2015.

 

3.2.     As payment in full for fees overdue to Alliacense on the Novatel, Garmin and Barnes & Nobel transactions, PDS shall pay
to Alliacense (1) $84,000 within 24 hours of the delivery of the Materials by Alliacense to DHG ("Installment
1"), and (2) $84,000 as "first money out" of subsequent Recovery ("Installment 2") (in the form of
direct payments).

 

3.3.     Within
48 hours of the receipt by Alliacense of Installment 1, the parties hereto shall cause the arbitration pending between
Alliacense and PDS (JAMS Ref. No.: 1110018059) (the "Arbitration") to be dismissed with prejudice. The parties
shall also execute mutual releases.

 

4.     Term
and Termination

 

4.1.     Other than any and all rights and obligations hereunder with respect to the Litigation Group:

 

4.1.1.     This Agreement will terminate six (6) years after the last-to-expire Patent unless earlier terminated by mutual written consent
of the parties or as set forth below. All payment obligations due prior to the expiration or termination of this Agreement shall
survive such expiration or termination for any reason whatsoever; and

 

4.1.2.     Either Party may terminate this Agreement in the event of a material breach by the other Party that is not cured, if capable of
being cured, within sixty (60) days of written notice of the breach

 

    	 	3	 

     

    

 

Confidential information has been omitted from portions of this
document, indicated by [*], and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to this omitted information.

 

4.2.     In
the event of termination:

 

4.2.1.     By
either party, PDS will remain responsible for and shall make all distributions of Recovery to MMP Licensing in
accordance with this Agreement for transactions concluded prior to such termination.

 

4.2.2.     By PDS, MMP Licensing shall be entitled to identify up to three (3)
entities from Exhibit A, for
which PDS shall pay MMP Licensing the fee otherwise due under Section 2 of this Agreement for Recovery related to any of the up
to three identified entities received by PDS within two (2) years following such termination.

 

5.     Confidentiality

 

5.1.     The
Parties shall maintain this Agreement and the terms of this Agreement as confidential, except
that each Party may disclose the terms of this Agreement to its subsidiaries
and: (i)
to any governmental authority having jurisdiction and requiring such disclosure; (ii)
in response to a valid subpoena or as otherwise may be required by law; (iii) as necessary in connection with any
tax, securities
or other filings, reports
or disclosures
that may be required under applicable laws or
regulations;
(iv) in
confidence , to a Party's
accountants, legal counsel, tax
advisors and other financial and legal advisors; (v)
as required during the course of litigation; (vi)
with obligations of confidentiality comparable to those contained herein, to
another Party or its legal or financial advisors in connection with a proposed merger, acquisition, spin-off, financing
or similar transaction of such Party or its Subsidiaries; (vii) as
necessary to file this Agreement or portions thereof
with governmental authorities; and
(ix) with the prior written consent of the other Party.

 

5.2.     Neither this Agreement nor any performance in pursuit of the Project, shall create any rights or licenses to any intellectual property between or among the parties, nor shall it create any obligation to share work product, communications, technology, trade secrets, know-how, show how and other proprietary developments and discoveries conceived or reduced to practice during the term of this agreement.

 

    	 	4	 

     

    

 

Confidential information has been omitted from portions of this
document, indicated by [*], and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to this omitted information.

 

6.     Dispute
Resolution

 

6.1     All
rights and obligations under this Agreement shall be resolved as if all
persons and all transactions related to this Agreement had their legal residence, situs,
and employment in Santa Clara County California. Within
15 days after written notice of the dispute, members of the most
senior management of the parties shall meet and exercise their commercially reasonable efforts to resolve any dispute under
this Agreement. The Agreement and all performances due hereunder shall continue unabated throughout the entire process and a final adjudication
in accordance with the terms hereof has been made from which no appeal or review can be undertaken. In
the event the parties fail to resolve their dispute after having undertaken the foregoing
efforts, then they may pursue their claims in the
appropriate Santa Clara County court.

 

7.     Representations
and Warranties

 

7.1.     Each
Party represents and warrants that it has the
right to enter this Agreement,
and to undertake the duties hereunder.

 

7.2.     MMP Licensing will undertake commercially reasonable efforts to execute the Project, but provides no representation or warranty as to the outcome.

  

7.3.     PDS
each represents and warrants that it will:

 

7.3.1.     Cooperate
with and support MMP Licensing in
its performance of the Project;
and

 

7.3.2.     Avoid
and refrain from any and all activity of any kind
or nature that may impede, impair,
obstruct, frustrate or otherwise interfere with the activities of MMP Licensing in its performance of the Project.

 

8.     Other

 

8.1.     This Agreement together with its Exhibits contains the entire agreement between the Parties.

 

    	 	5	 

     

    

 

Confidential information has been omitted from portions of this
document, indicated by [*], and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to this omitted information.

 

IN WITNESS WHEREOF,
the parties have hereunto set their hands
and seals as of August 10, 2016.

 

	
        PDS

         

        “LICENSOR”
	
        MMP LICENSING

         

        “LICENSEE”

	
         

        By: /s/ Carl Johnson

               Carl Johnson

        Title: Manager

        Date: 10 August 2016

         

         

        By: /s/ Swamy Venkidu

        Title: Manager

        Date: 10 August 2016
	
         

        By: /s/ Mac Leckrone

               Mac Leckrone

        Title: Manager

        Date: 10 August 2016

	 	
        Also Acknowledged and Agreed:

         

        By: /s/ Mac Leckrone

               Mac Leckrone

        Title: President, Alliacnese

        Date: 10 August 2016

 

 

 

 

 

    	 	6	 

     

    

 

Confidential information has been omitted from portions of this
document, indicated by [*], and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to this omitted information.

 

EXHIBIT A

 

PROJECT GROUP COMPANIES

 

[*]

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	7	 

     

    

 

Confidential information has been omitted from portions of this
document, indicated by [*], and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to this omitted information.

 

 

[*]

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	8	 

     

    

 

Confidential information has been omitted from portions of this
document, indicated by [*], and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to this omitted information.

 

[*]

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    	 	9	 

     

    

 

Confidential information has been omitted from portions of this
document, indicated by [*], and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to this omitted information.

 

ADDENDUM
B

FORM OF LICENSE

 

 

This License ("License") is
entered into by and between Phoenix Digital Solutions LLC, a Delaware limited liability company , having its principal place
of businessat 701 Palomar Airport Road, Suite 170, Carlsbad, CA 92011-1045 ("Licensor'') on the one hand, and MMP
Licensing LLC, a California limited liability company with its principal place of business for these purposes at 2310
Homestead Road, Los Altos, CA, Suite C1-505, hereinafter "Licensee" on the other hand.

 

NOW THEREFORE, for and
in consideration of the mutual covenants herein contained as well as of other good and valuable consideration the receipt and sufficiency
of which is hereby acknowledged, and pursuant to that certain Agreement between Licensee and Licensor dated 10 August 2016 (the
"Agreement"), it is covenanted and agreed by and between the parties hereto that:

 

1.     Subject
Matter.

 

"Project Patents"
means the patents and applications scheduled at Exhibit A, entitled "Schedule of Project Patents."

 

"Commercialize" means to make and
have made, use and have used, sell and have sold, import and have imported.

 

2.     Conveyance.

 

2.1.     Licensor
hereby grants to Licensee:

 

2.1.1.     A
world-wide, irrevocable, non-exclusive license under the Project Patents to Commercialize Licensee products; and

 

2.1.2.     With respect to the Litigation Companies, a world-wide, irrevocable, exclusive license under the Project Patents to:

 

2.1.2.1.     Regulate and control by license, sublicense, affiliation, or other agreement the practice and/or use of any and all of the Project
Patents; and

 

2.1.2.2.     
Otherwise pursue the commercialization and enforcement of any and all claims of the Project Patents, including the Commercialization
of any and all products and/or services and the practice of any and all methods and processes covered by any and all claims of
any or all of the Project Patents; and

 

2.1.2.3.     
Sue on and collect for its own use and benefit all claims and/or entitlements with respect to damages by reason of past, present
and future infringement or use of any and all of the Project Patents; and,

 

2.1.2.4.      
Pursue in its own name and for
its own use and
benefit all remedies of whatsoever kind
or nature (including injunctive
relief) relating to
the past, present, or
future infringement or use of
any and all of the Project
Patents.

 

    	 	10	 

     

    

 

Confidential information has been omitted from portions of this
document, indicated by [*], and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to this omitted information.

 

3.     Attachments.

 

 • Exhibit A: Schedule of Project Patents

 

 

IN
WITNESS WHEREOF, the parties have hereunto set their hands
and seals as of August 10, 2016.

 

 

	
        PDS

         

        “LICENSOR”
	
        MMP LICENSING

         

        “LICENSEE”

	
         

        By: /s/ Carl Johnson

               Carl Johnson

        Title: Manager

        Date: 10 August 2016

         

         

        By: /s/ Swamy Venkidu

        Title: Manager

        Date: 10 August 2016
	
         

        By: /s/ Mac Leckrone

               Mac Leckrone

        Title: Manager

        Date: 10 August 2016

 

 

 

 

 

 

 

 

 

 

    	 	11	 

     

    

 

Confidential information has been omitted from portions of this
document, indicated by [*], and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested
with respect to this omitted information.

 

EXHIBIT
A

SCHEDULE
OF PROJECT PATENTS

 

	 	Country	 	 	Patent
    #	 	Filing	 	 	App
    #	 	Issue	 	 	Title	 
	us	5,440
    ,749	03-Aug-89	07/389
    ,334	08-Aug-95	High
    Performance,
    Low Cost Microprocessor with
    Combination Stack and Register
    Architecture
	us	5,530 890	07-Jun-95	08/480 206	25-Jun-96	High Performance, Low Cost Microprocessor
	us	5,530 890 C1	16-Jan-09	90/009 388	01-Mar-11	High Performance, Low Cost Microprocessor
	us	5,659,703	07-Jun-95	08/482,185	19-Aug-97	Microprocessor System With Hierarchical Stack And Method Of Operation
	us	5,809,336	07-Jun-95	08/484,918	15-Sep-98	High Performance Microprocessor Having Variable Speed System Clock
	us	6,598,148 C1	21-Sep-06	90/008,227	06-Sep-11	High Performance Microprocessor Having Variable Speed System Clock
	us	6,598 ,148 C1	29-May-09	90/010,562	06-Sep-11	High Performance Microprocessor Having Variable Speed System Clock
	us	5,809,336 C1	19-Oct-06	90/008,306	15-Dec-09	High Performance Microprocessor Having Variable Speed System Clock
	us	5,809,336 C1	17-Nov-06	90/008,237	15-Dec-09	High Performance Microprocessor Having Variable Speed System Clock
	us	5,809,336 C1	30-Jan-07	90/008,474	15-Dec-09	High Performance Microprocessor Having Variable Speed System Clock
	us	5,809,336 C2	24-Aug-09	90/009 ,457	23-Nov-10	High Performance Microprocessor Having Variable Speed System Clock
	us	5 ,784,584	07-Jun-95	08/484,935	21-Jul-98	High Performance Microprocessor Using Instructions That Operate Within Instruction Groups
	us	5,784,584 C1	15-Nov-06	90/008,225	21-Jul-09	High Performance Microprocessor Using Instructions That Operate Within Instruction Groups
	us	 	19-Oct-06	90/008,299	21-Jul-09	High Performance Microprocessor Using Instructions That Operate Within Instruction Groups
	us	5,604,915	07-Jun-95	08/485 ,031	18-Feb-97	Data Processing System Having Load Dependent Bus Terminal
	us	5,440,749 C1	31-Mar-08	90/009,034	07-Jun-11	High Performance, Low Cost Microprocessor Architecture
	us	5,440,749 C1	16-Jan-09	90/009,389	07-Jun-11	High Performance, Low Cost Microprocessor Architecture
	us	5,440 ,749 C1	30-Apr-09	90/010,520	07-Jun-11	High Performance, Low Cost Microprocessor Architecture
	IR	0870226	04-Oct-96	96934069.4	21-Mav-03	RISC Microprocessor Architecture
	JP	JP 3739797	04-Oct-96	1996-515848	11-Nov-05	RISC Microprocessor Architecture
	JP	3955305	22-Aug-05	2005-240441	11-Mav-07	RISC Microprocessor Architecture
	JP	4859616	10-Oct-06	2006-276681	11-Nov-11	RISC Microprocessor Architecture
	UK	0870226	04-Oct-96	96934069.4	21-Mav-03	RISC Microprocessor Architecture
	JP	 	12-Nov-08	2008-290229	 	RISC Microprocessor Architecture
	JP	 	15-Jun-09	2009-141967	 	RISC Microprocessor Architecture
	us	 	31-Oct-07	11/981,278	 	Using Breakpoints for Debugging in a RISC Microprocessor Architecture
	us	6,598,148	29-Jul-98	09/124,623	22-Jul-03	High Performance Microprocessor Having Variable Speed System Clock
	DE	DE 69033568 .7	02-Aug-90	97200767.8	14-Jun-00	High Performance, Low Cost Microprocessor
	EPO	EP 0786730	14-Mar-97	97200767 .8	14-Jun-00	High Performance, Low Cost Microprocessor
	FR	0786730	02-Aug-90	97200767 .8	14-Jun-00	High Performance, Low Cost Microprocessor
	IT	0786730	02-Aug-90	97200767.8	14-Jun-00	High Performance  Low Cost Microprocessor
	JP	JP 2966085	02-Aug-90	02-511130	25-Oct-99	High Performance, Low Cost Microprocessor
	NL	0786730	02-Aug-90	97200767 .8	14-Jun-00	High Performance  Low Cost Microprocessor
	UK	0786730	02-Aug-90	97200767 .8	14-Jun-00	High Performance, Low Cost Microprocessor
	us	 	06-Oct-95	60/005,408	 	RISC Microprocessor Architecture
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 

Any other U.S. or Non
U.S. patent or application issued or pending which is a continuation, divisional, continuation in part, reissue, or reexamination
of any of the scheduled patents or applications.

 

    	 	12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00261-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00261-of-00352.parquet"}]]